Strategy Based Technique to Enhance Memory (STEM) for Improving New Learning and Memory (NLM) in Moderate to Severe TBI
STEM
1 other identifier
interventional
80
1 country
1
Brief Summary
The purpose of this research study is to investigate the effectiveness of a memory enhancement technique in persons with a Traumatic Brian Injury (TBI). The study is designed to research how well this technique can help people with TBI improve their memory and their ability to function better in everyday life
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2017
CompletedFirst Submitted
Initial submission to the registry
June 18, 2019
CompletedFirst Posted
Study publicly available on registry
August 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2024
CompletedMarch 20, 2025
February 1, 2024
6.7 years
June 18, 2019
March 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Self Report Deficits in Daily Life
Perceived Deficits Questionnaire215 * •20 items; evaluates everyday situations in which cognition has a role * •Cronbach's Alpha (lower bound reliability) = .93
5 weeks from baseline (short term follow-up) and 7 months from baseline (long term follow-up)
Study Arms (2)
STEM
EXPERIMENTALThe treatment group (TX) will complete 8 sessions of STEM (2 sessions per week for 4 weeks), Sessions are approximately 30-45 minutes long.
Controlled
NO INTERVENTIONDuring weeks 2-5, one group will undergo a memory enhancement protocol, used to improve memory functioning in individuals with neurological injuries. The other group will serve as a control group and complete memory exercises with the researcher.
Interventions
The treatment group (TX) will complete 8 sessions of SME (2 sessions per week for 4 weeks), de-signed to teach the concepts of SG, SL and RP and the application of these techniques in daily life. Sessions are approximately 30-45 minutes long.
Eligibility Criteria
You may qualify if:
- In order to participate in this study I must meet the following requirements:
- I am between the ages of 18-65.
- I have had a traumatic brain injury (TBI) at least 1 year ago.
- I can read and speak English fluently.
- I have difficulties with learning and memory skills.
You may not qualify if:
- I have had a prior stroke or neurological injury/disease other than TBI.
- I have a history of significant psychiatric illness (for example, bipolar disorder, schizophrenia, or psychosis) or a current diagnosis of Major Depressive Disorder, Schizophrenia, Bipolar Disorder I or II.
- I have a significant alcohol or drug abuse history (inpatient Treatment).
- I am taking certain medications that might exclude me from the research. The study team will review my medications with me.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kessler Foundation
East Hanover, New Jersey, 07936, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nancy Chiaravalloti, PhD
Kessler Foundation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Once enrolled, participants will be randomly assigned to the TX or CTL group via a computerized random number generator coordinated by the statistician, who will not be blinded. Group assignment will be concealed. Both the participant and the examiner conducting the baseline and outcome assessments will be blind to group membership.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of NNL & TBI
Study Record Dates
First Submitted
June 18, 2019
First Posted
August 13, 2019
Study Start
December 1, 2017
Primary Completion
July 31, 2024
Study Completion
July 31, 2024
Last Updated
March 20, 2025
Record last verified: 2024-02